MDxHealth S.A.
MDXH
Rank in Stocks
#21635
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Share Price
$3.39
Last synced: 2023-12-15
Market Cap
$96.16M
Change (1 day)
-1.73%
Change (1 year)
0.01%
Country
BE
Trade MDxHealth S.A. (MDXH)
Category
Healthcare
Stock price history for MDxHealth S.A. (MDXH)
Highest end of day price: $3.30 on 2023-12-01
Lowest end of day price: $109.85 on 2008-08-01
Lowest end of day price: $109.85 on 2008-08-01
Stock price history of MDxHealth S.A. from 2008 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2023 | -52.10% |
| 2022 | -33.51% |
| 2021 | 0.16% |
| 2020 | -8.63% |
| 2019 | -47.39% |
| 2018 | -49.31% |
| 2017 | -10.95% |
| 2016 | 3.69% |
| 2015 | -5.94% |
| 2014 | 20.96% |
| 2013 | 75.72% |
| 2012 | 7.83% |
| 2011 | -80.58% |
| 2008 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $177.93 | 21.98% |
US
|
